BGM (BGM) | Stock Overview & Key Data
BGM Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $110.00 on January 11, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BGM
BGM
|
65.80M Micro-cap | 43.75% | 35.29% | -50.54% | -91.10% | -87.15% | -97.19% | -91.74% | -98.32% | -99.13% | -99.13% | -99.13% |
|
Zoetis
ZTS
|
49.75B Large-cap | 0.16% | 3.42% | -31.08% | -32.94% | -36.81% | -51.58% | -53.40% | -57.08% | 71.34% | 156.59% | 156.59% |
|
Haleon Plc - ADR
HLN
|
42.40B Large-cap | 2.02% | 1.23% | -13.29% | -7.73% | -9.30% | -16.01% | 8.43% | 23.21% | 23.21% | 23.21% | 23.21% |
|
Aurora Cannabis
ACB
|
200.44M Micro-cap | -2.95% | -8.04% | -28.14% | -36.47% | -39.40% | -48.03% | -43.70% | -96.52% | -93.07% | -95.89% | -95.89% |
|
Anika Therapeutics
ANIK
|
221.65M Micro-cap | 0.07% | -2.01% | 1.74% | 52.66% | 56.26% | 34.68% | -44.60% | -63.19% | -70.02% | 116.79% | 39.13% |
| 203.22M Micro-cap | -3.74% | -3.74% | -27.46% | -42.78% | -40.46% | -24.29% | -39.77% | -90.89% | -96.46% | -96.46% | -96.46% |
Ownership & Short Interest
Calculate Your BGM Investment Returns
Long-Term Investment Performance Analysis
BGM stock price in Jan 2021 was $43.75, A $1,000.00 lump sum investment in BGM made 5 years ago would be worth approximately $10.51 today, representing a negative return of -98.95%. This translates to an annualized return (CAGR) of -56.82%.
5 Years 5 Months Investment Scenario (Jan 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is BGM's 52-week high and low?
- In the last 52 weeks, BGM reached a high of $14.42 (on June 16, 2025) and a low of $0.26 (on May 18, 2026).
- What is the market cap and P/E ratio for BGM?
- Curious about BGM's size and valuation? Its market capitalization stands at 65.80M. When it comes to valuation, the P/E ratio (trailing twelve months) is 15.00, and the forward P/E (looking ahead) is N/A.
- Does BGM pay dividends? If so, what's the yield?
- As for dividends, BGM isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are BGM's main competitors or similar companies to consider before investing?
When looking at BGM, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS49.75B Healthcare Drug Manufacturers - Specialty & Generic -51.58% -53.40% Haleon Plc - ADR
HLN42.40B Healthcare Drug Manufacturers - Specialty & Generic -16.01% 8.43% Aurora Cannabis
ACB200.44M Healthcare Drug Manufacturers - Specialty & Generic -48.03% -43.70% Anika Therapeutics
ANIK221.65M Healthcare Drug Manufacturers - Specialty & Generic 34.68% -44.60% Organigram Holdings
OGI203.22M Healthcare Drug Manufacturers - Specialty & Generic -24.29% -39.77% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for BGM Group Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of BGM's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -3.27%, the Debt to Equity ratio from the most recent quarter is 0.97, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for BGM?
- Looking at BGM's growth, its revenue over the trailing twelve months (TTM) was $25M. Compared to the same quarter last year (YoY), quarterly revenue grew by 13.90%, and quarterly earnings saw a YoY growth of N/A.
- How much of BGM stock is held by insiders and institutions?
- Wondering who owns BGM stock? Company insiders (like executives and directors) hold about 63.68% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.17%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.